DCI Welcomes New Heme AD

Jacob Keller
Jacob Keller, MHA, has joined DCI as administrative director for Hematologic Malignancies & Cellular Therapies (HMCT), effective January 1.
 
Keller came to Duke in 2020 as a Duke University Hospital an administrative fellow. The final six months of his fellowship focused on Oncology, during which time he worked on workflow enhancements and access initiatives, among other projects.
 
Gabriel Alcantara, MBA, the previous administrative director for HMCT, has taken on a larger role as the Division Administrator for Medical Oncology and HMCT.
Topics
hematology/oncology